We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

55 hedge funds and large institutions have $303M invested in Entellus Medical, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

24% more capital invested

Capital invested by funds: $245M → $303M (+$57.9M)

8% more funds holding

Funds holding: 5155 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
25
Reduced
9
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$98.6M +$25 +1 +0%
SHI
2
SV Health Investors
Massachusetts
$90.3M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$32.6M +$6.52M +258,100 +26%
RIM
4
RS Investment Management
California
$21.6M +$6.27M +248,116 +42%
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$7.2M -$409K -16,181 -5%
KCM
6
Kingdon Capital Management
New York
$6.86M +$506K +20,000 +8%
Wells Fargo
7
Wells Fargo
California
$6.46M +$1.42K +56 +0%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$5.69M -$312K -12,343 -5%
NCGI
9
Next Century Growth Investors
Minnesota
$3.9M +$16.2K +641 +0.4%
BFA
10
BlackRock Fund Advisors
California
$3.75M -$15.1K -597 -0.4%
American Century Companies
11
American Century Companies
Missouri
$3.12M -$6.6K -261 -0.2%
Vanguard Group
12
Vanguard Group
Pennsylvania
$2.81M +$1.1M +43,337 +66%
WA
13
Wasatch Advisors
Utah
$2.5M +$470K +18,577 +24%
WRF
14
Waddell & Reed Financial
Kansas
$2.27M
BIT
15
BlackRock Institutional Trust
California
$1.5M +$392K +15,518 +37%
Federated Hermes
16
Federated Hermes
Pennsylvania
$1.49M
Northern Trust
17
Northern Trust
Illinois
$1.36M +$954K +37,732 +254%
PI
18
Putnam Investments
Massachusetts
$1.2M +$1.17M +46,356 New
State Street
19
State Street
Massachusetts
$1.16M +$1.13M +44,676 New
WSA
20
Wall Street Associates
California
$1.03M
Geode Capital Management
21
Geode Capital Management
Massachusetts
$909K +$888K +35,139 New
MOACM
22
Mutual of America Capital Management
New York
$676K +$169K +6,700 +34%
Ameriprise
23
Ameriprise
Minnesota
$667K
Bank of New York Mellon
24
Bank of New York Mellon
New York
$631K +$298K +11,788 +93%
BIM
25
BlackRock Investment Management
Delaware
$529K +$105K +4,139 +25%

ENTL Hedge Fund Activity: Q2 2015 in Review

55 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q2 2015, worth a combined $303M — up 24% from $245M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ENTL positions and 11 closed out — a net gain of 4 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $6.52M. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $3.29M sold.

  • 55 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q2 2015, up from 51 in Q1 2015.
  • Funds reported $303M of Entellus Medical, Inc. Common Stock stock for Q2 2015, up 24% quarter-over-quarter.
  • 15 funds opened new Entellus Medical, Inc. Common Stock positions in Q2 2015 and 11 closed out, a net change of +4 holders.
  • The largest Entellus Medical, Inc. Common Stock buyer in Q2 2015 was Fidelity Investments, an estimated $6.52M added.
  • The largest Entellus Medical, Inc. Common Stock seller in Q2 2015 was Ghost Tree Capital, an estimated $3.29M sold.

Based on aggregated 13F filings for Q2 2015.